Ropocamptide

DB16532InvestigationalProtein Based Therapies

Ropocamptide is a human cathelicidin that inhibits viral replication and while also playing a role in host defense against infection.

Mechanism
Curator reviewed
Also known as
CAS001 · LL-37 antiviral peptide
Code names
LL-37

Resolves to

What you can answer from here — as of July 08, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
12+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ropocamptide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account